Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptors

Journal of Virology

Volumn 78, Issue 16, 2004, Pages 8860-8867

  Kumar, A S Manoj ^a   Reddi, Honey V ^a   Kung, Aisha Y ^a   Dal Canto, Mauro ^b   Lipton, Howard L ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c EVANSTON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; SIALIC ACID; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; DEMYELINATION; MALE; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS ADSORPTION; VIRUS VIRULENCE;

ANIMALS; ANIMALS, OUTBRED STRAINS; CAPSID; CARDIOVIRUS INFECTIONS; CELL LINE; CRICETINAE; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MULTIPLE SCLEROSIS; MUTATION; N-ACETYLNEURAMINIC ACID; RECEPTORS, VIRUS; THEILOVIRUS; VIRION;

EID: 3543063967     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.16.8860-8867.2004     Document Type: Article

References (51)

1. Ahmed, R., L. A. Morrison, and D. M. Knipe. 1996. Persistence of viruses, p. 219-250. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
2. Barton, E. S., D. H. Ebert, J. C. Forrest, J. L. Connolly, T. Valyi-Nagy, J. D. Wetzel, and T. S. Dermody. 2003. Utilization of sialic acid as a co-receptor is required for reovirus-induced biliary disease. J. Clin. Investig. 111:1823-1833.
3. Bauer, P. H., R. T. Bronson, S. C. Fung, R. Freund, T. Stehle, S. C. Harrison, and T. L. Benjamin. 1995. Genetic and structural analysis of a virulence determinant in polyomavirus VP1. J. Virol. 69:7925-7931.
4. Bauer, P. H., C. Cui, T. Stehle, S. C. Harrison, J. A. DeCaprio, and T. L. Benjamin. 1999. Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse. J. Virol. 73:5826-5832.
5. Blakemore, W. F., C. J. Welsh, P. Tonks, and A. A. Nash. 1988. Observations on demyelinating lesions induced by Theiler's virus in CBA mice. Acta Neuropathol. 76:581-589.
6. Brahic, M., A. T. Haase, and E. Cash. 1984. Simultaneous in situ detection of viral RNA and antigens. Proc. Natl. Acad. Sci. USA 81:5445-5448.
7. Calenoff, M. A., K. S. Faaberg, and H. L. Lipton. 1990. Genomic regions of neurovirulence and attenuation in Theiler's murine encephalomyelitis. Proc. Natl. Acad. Sci. USA 87:978-982.
8. Clatch, R. J., H. L. Lipton, and S. D. Miller. 1986. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 136:920-926.
9. Clatch, R. J., S. D. Miller, R. Metzner, M. C. Dal Canto, and H. L. Lipton. 1990. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176:244-254.
10. Denizot, F., and R. Lang. 1986. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89:271-277.
11. Deutscher, S. L., N. Nuwayhid, P. Stanley, and E. B. Briles. 1984. Translocation across Golgi vesicle membranes: a CHO glycosylation mutant deficient in CMP-sialic acid transport. Cell. 39:295-299.
12. Fabian, P. H., and J. D. Coulter. 1985. Transneuronal transport of lectins. Brain Res. 344:41-48.
13. Foster, L. M., T. Phan, A. N. Verity, D. Bredesen, and A. T. Campagnoni. 1993. Generation and analysis of normal and shiverer temperature-sensitive immortalized cell lines exhibiting phenotypic characteristics of oligodendrocytes at several stages of differentiation. Dev. Neurosci. 15:100-119.
14. Fotiadis, C., D. R. Kilpatrick, and H. L. Lipton. 1991. Comparison of the binding characteristics to BHK-21 cells of viruses representing the two Theiler's virus neurovirulence groups. Virology 182:365-370.
15. Gerety, S. J., K. M. Rundell, M. C. Dal Canto, and S. D. Miller. 1994. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:919-929.
16. Gosselin, A.-S., Y. Simonin, F. Guivel-Benhassine, V. Rincheval, J.-L. Vayssière, B. Mignotte, F. Colbère-Garapin, T. Couderc, and B. Blondel. 2003. Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells. J. Virol. 77:790-798.
17. Grant, R. A., D. J. Filman, R. S. Fujinami, J. P. Icenogle, and J. M. Hogle. 1992. Three-dimensional structure of Theiler's virus. Proc. Natl. Acad. Sci. USA 89:2061-2065.
18. Hickey, W. F. 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36:118-124.
19. Jarousse, N., R. A. Grant, J. M. Hogle, L. Zhang, A. Senkowski, R. P. Roos, T. Michiels, M. Brahic, and A. McAllister. 1994. A single amino acid change determines persistence of a chimeric Theiler's virus. J. Virol. 68:3364-3368.
20. Jelachich, M. L., C. Bramlage, and H. L. Lipton. 1999. Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis. J. Virol. 73:3227-3235.
21. Jelachich, M. L., and H. L. Lipton. 2001. Theiler's murine encephalomyclitis virus induces apoptosis in gamma interferon activated M1 differentiated myelomonocytic cells through a mechanism involving tumor necrosis factor alpha (TNF-α) and TNF-α-related apoptosis-inducing ligand. J. Virol. 75:5930-5938.
22. Jnaoui, K., M. Minet, and T. Miehiels. 2002. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenesis. J. Virol. 76:8138-8147.
23. Kim, S., U. Boege, S. Krishnaswamy, I. Minor, T. J. Smith, M. Luo, D. G. Scraba, and M. G. Rossmann. 1990. Conformational variability of a picornavirus capsid: pH-dependent structural changes of Mengo virus related to its host receptor attachment site and disassembly. Virology 175:176-190.
24. Krempl, C., M.-L. Ballesteros, G. Zimmer, L. Enjuanes, H.-D. Klenk, and G. Herrler. 2000. Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination- deficient mutants. J. Gen. Virol. 81:489-496.
25. Kumar, A. S. M., P. Kallio, M. Luo, and H. L. Lipton. 2003. Amino acid substitutions in VP2 residues contacting sialic acid in low-neurovirulence BeAn virus dramatically reduce viral binding and spread of infection. J. Virol. 77:2709-2716.
26. Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367-382.
27. Lassmann, H., M. Schmied, K. Vass, and W. F. Hickey. 1993. Bone marrow derived elements and resident microglia in brain inflammation. Glia 7:19-24.
28. Lipton, H. L. 1975. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 11:1147-1155.
29. Lipton, H. L., and D. H. Gilden. 1996. Viral diseases of the central nervous system: persistent infections, p. 853-867. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven, Philadelphia, Pa.
30. Lipton, H. L., G. Twaddle, and M. L. Jelachieh. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69:2525-2533.
31. Luo, M., C. He, K. S. Toth, C. X. Zhang, and H. L. Lipton. 1992. Three-dimensional structure of Theiler's murine encephalomyelitis virus (BeAn strain). Proc. Natl. Acad. Sci. USA 89:2409-2413.
32. Markovic-Plese, S., and H. F. McFarland. 2001. Immunopathogenesis of the multiple sclerosis lesion. Curr. Neurol. Neurosci. Rep. 1:257-262.
33. Marschall, M., H. Meier-Ewert, G. Herrler, G. Zimmer, and H. F. Maassab. 1997. The cell receptor level is reduced during persistent infection with influenza C virus. Arch. Virol. 142:1155-1164.
34. McAllister, A., F. Tangy, C. Aubert, and M. Brahic. 1989. Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts. Microb. Pathog. 7:381-388.
35. McAllister, A., F. Tangy, C. Aubert, and M. Brahic. 1990. Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J. Virol. 64:4252-4257. (Erratum, 67:2427, 1993.)
36. Michiels, T., N. Jarousse, and M. Brahic. 1995. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus. Virology 214:550-558.
37. Miller, S. D., C. VanderLugt, W. S. Begolka, W. Pao, R. L. Yauch, K. L. Neville, Y. Katz-Levy, A. Carrizosa, and B. S. Kim. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1113-1136.
38. Pavio, N., T. Couderc, S. Girard, J.-Y. Sgro, B. Blondel, and F. Colbere-Garapin. 2000. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus. Virology 274:331-342.
39. Pena-Rossi, C., M. Delcroix, I. Huitinga, A. McAllister, N. van Rooijen, E. Claassen, and M. Brahic. 1997. Role of macrophages during Theiler's virus infection. J. Virol. 71:3336-3340.
40. Reddi, H. V., and H. L. Lipton. 2002. Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses. J. Virol. 76:8400-8407.
41. Reed, L. J., and H. A. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
42. Rodriguez, M., W. P. Lafuse, J. Leibowitz, and C. S. David. 1986. Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (1a antigens). Neurology 36:964-970.
43. Rodriguez, M., J. L. Leibowitz, and P. W. Lampert. 1983. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13:426-433.
44. Shah, A. H., and H. L. Lipton. 2002. Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment. Virology 304:443-450.
45. Simas, J. P. and J. K. Fazakerley. 1996. The course of disease and persistence of virus in the central nervous system varies between individual CBA mice infected with the BeAn strain of Theiler's murine encephalomyelitis virus. J. Gen. Virol. 77:2701-2711.
46. Steinman, L., R. Martin, C. Bernard, P. Conlon, and J. R. Oksenberg. 2002. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25:491-505.
47. Trottier, M., B. P. Schlitt, and H. L. Lipton. 2002. Enhanced detection of Theiler's virus RNA copy equivalents in the mouse central nervous system by real-time RT-PCR. J. Virol. Methods 103:89-99.
48. Vlaycheva, L. A., and T. J. Chambers. 2002. Neuroblastoma cell-adapted yellow fever 17D virus: characterization of a viral variant associated with persistent infection and decreased virus spread. J. Virol. 76:6172-6184.
49. Wada, Y., M. L. Pierce, and R. S. Fujinami. 1994. Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J. Virol. 68:1219-1223.
50. Zhou, L., Y. Luo, Y. Wu, J. Tsao, and M. Luo. 2000. Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J. Virol. 74:1477-1485.
51. Zurbriggen, A., C. Thomas, M. Yamada, R. P. Roos, and R. S. Fujinami. 1991. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J. Virol. 65:1929-1937.